No Data
No Data
Express News | Lingkang Pharmaceutical: Application for clinical trial of esomeprazole magnesium sodium bicarbonate dry suspension (I) obtained acceptance notice
Lionco Pharmaceutical Group Co.,Ltd.'s (SHSE:603669) Biggest Owners Are Private Companies Who Got Richer After Stock Soared 18% Last Week
Key Insights Lionco Pharmaceutical GroupLtd's significant private companies ownership suggests that the key decisions are influenced by shareholders from the larger public The top 2 shareholders own
Lingkang Pharmaceutical (603669.SH) released annual results, with a net loss of 151 million yuan to mother, a year-on-year decrease of 22.65%
According to Zhitong Finance App News, Lingkang Pharmaceutical (603669.SH) released its 2023 annual report. The group achieved operating income of 197 million yuan, a year-on-year decrease of 31.95%; achieved a net loss attributable to shareholders of listed companies of 151 million yuan, a year-on-year narrowing of 22.65%; realized a net loss attributable to shareholders of listed companies after deducting non-recurring profit and loss of 182 million yuan, a year-on-year decrease of 10.9%; a basic loss per share. The company is mainly engaged in R&D, production and sales of chemical prescription drugs. The company adheres to the market-based product development strategy. The product variety is rich, the structure is reasonable, and numerous
Lingkang Pharmaceutical (603669.SH) announced first-quarter results, with a net loss of 16.0415 million yuan
Lingkang Pharmaceutical (603669.SH) released its report for the first quarter of 2024. The group achieved operating revenue during the period...
Even After Rising 16% This Past Week, Lionco Pharmaceutical GroupLtd (SHSE:603669) Shareholders Are Still Down 44% Over the Past Three Years
Lionco Pharmaceutical Group Co.,Ltd. (SHSE:603669) shareholders will doubtless be very grateful to see the share price up 35% in the last month. But that doesn't change the fact that the returns ov
Revenues Not Telling The Story For Lionco Pharmaceutical Group Co.,Ltd. (SHSE:603669) After Shares Rise 35%
Lionco Pharmaceutical Group Co.,Ltd. (SHSE:603669) shareholders are no doubt pleased to see that the share price has bounced 35% in the last month, although it is still struggling to make up recently
No Data